Charmacy Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	753.6	563.15	634.2	492.67	630.17
Short-Term Investments	-	10.7	10.56	11.13	11.59
Cash & Short-Term Investments	753.6	573.86	644.76	503.81	641.76
Cash Growth	31.32%	-11.00%	27.98%	-21.50%	6.60%
Accounts Receivable	1,261	1,226	965.35	865.26	731.26
Other Receivables	13.08	43.12	41.49	116.91	42.8
Receivables	1,274	1,270	1,007	982.17	774.06
Inventory	796.25	655.91	775.84	586.85	509.16
Prepaid Expenses	-	1.84	-	-	-
Other Current Assets	736.94	528.84	384.56	389.53	313.25
Total Current Assets	3,561	3,030	2,812	2,462	2,238
Property, Plant & Equipment	294.57	317.6	328.55	294.08	348.44
Goodwill	6	6	6.02	6.02	6.02
Other Intangible Assets	68.33	72.49	76.72	80.86	143.03
Long-Term Deferred Tax Assets	11.48	7.64	7.38	6.8	8.16
Long-Term Deferred Charges	18.69	22.91	16.98	16.34	19.21
Total Assets	3,960	3,457	3,248	2,866	2,763
Accounts Payable	1,405	826.51	936.49	876.78	809.77
Accrued Expenses	76.44	61.29	58.35	86.48	47.84
Short-Term Debt	1,119	1,350	1,338	1,166	1,193
Current Portion of Long-Term Debt	-	1.22	-	-	31.78
Current Portion of Leases	-	8.78	6.59	4.15	2.97
Current Income Taxes Payable	-	11.72	12.85	27.05	6.41
Current Unearned Revenue	5.02	2.1	19.49	13.53	46.66
Other Current Liabilities	675.2	526.5	247.55	81.98	20.44
Total Current Liabilities	3,281	2,789	2,619	2,256	2,159
Long-Term Debt	38.1	13.8	-	-	86.87
Long-Term Leases	24.21	35.17	30.39	15.75	12.49
Long-Term Unearned Revenue	-	-	-	-	0.3
Long-Term Deferred Tax Liabilities	0.19	0.38	0.6	0.06	0.4
Total Liabilities	3,344	2,838	2,650	2,271	2,259
Common Stock	108	108	108	108	108
Additional Paid-In Capital	-	278	278	278	278
Retained Earnings	229.37	231.7	210.82	208.07	117.11
Comprehensive Income & Other	278.99	0.99	0.99	0.99	0.99
Total Common Equity	616.36	618.69	597.81	595.06	504.1
Shareholders' Equity	616.36	618.69	597.81	595.06	504.1
Total Liabilities & Equity	3,960	3,457	3,248	2,866	2,763
Total Debt	1,182	1,409	1,375	1,186	1,327
Net Cash (Debt)	-427.91	-835.6	-729.76	-681.72	-685.4
Net Cash Per Share	-3.96	-7.74	-6.76	-6.31	-6.35
Filing Date Shares Outstanding	107.98	108	108	108	108
Total Common Shares Outstanding	107.98	108	108	108	108
Working Capital	279.79	241.39	193.14	206.77	79.3
Book Value Per Share	5.71	5.73	5.54	5.51	4.67
Tangible Book Value	542.04	540.2	515.06	508.18	355.04
Tangible Book Value Per Share	5.02	5.00	4.77	4.71	3.29
Buildings	-	298.21	298.21	269.2	329.71
Machinery	-	80.86	81.06	76.69	101.72

Source: S&P Global Market Intelligence. Standard template. Financial Sources.